A detailed history of Deep Track Capital, LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 1,304,721 shares of AXSM stock, worth $105 Million. This represents 3.44% of its overall portfolio holdings.

Number of Shares
1,304,721
Previous 1,000,000 30.47%
Holding current value
$105 Million
Previous $79.6 Million 30.82%
% of portfolio
3.44%
Previous 3.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$69.39 - $97.64 $21.1 Million - $29.8 Million
304,721 Added 30.47%
1,304,721 $104 Million
Q4 2023

Feb 14, 2024

SELL
$57.42 - $83.61 $8.08 Million - $11.8 Million
-140,745 Reduced 12.34%
1,000,000 $79.6 Million
Q3 2023

Nov 14, 2023

BUY
$69.25 - $82.21 $52.4 Million - $62.2 Million
756,545 Added 196.91%
1,140,745 $79.7 Million
Q2 2023

Aug 14, 2023

BUY
$58.41 - $90.35 $22.4 Million - $34.7 Million
384,200 New
384,200 $27.6 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.45B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.